Noelle Cloven, MD
Gynecologic Oncology · Fort Worth, TXNPI 1477518686
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,758 of the $17,948 with a category attached, or 82.2%. 24 manufacturers reported payments, led by AstraZeneca at 31.7% of the total. 2025 is the largest year on record at $5,166, more than ten times the $75 reported in 2019.
Across 63 payments — averaging $284.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$6K
- GSK$4K
- AbbVie$3K
- Genmab U.S., Inc.$2K
- Daiichi Sankyo Inc.$2K
- Merck$584
- plus $1K from 18 others
Across 1,055 payments — averaging $6905.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$3.7M
- Tesaro, Inc.$1.2M
- Merck$723K
- Genmab U.S., Inc.$698K
- Pfizer$525K
- Alkermes, Inc.$134K
- plus $334K from 6 others
What the payments were for
- Consulting fees$14,75882%
- Travel & lodging$2551%
- Food & beverage$2,91516%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $5,691 |
| GSK | 8 | $3,670 |
| AbbVie | 9 | $2,554 |
| Genmab U.S., Inc. | 9 | $2,266 |
| Daiichi Sankyo Inc. | 1 | $1,938 |
| Merck | 8 | $584 |
| Corcept Therapeutics | 3 | $306 |
| Stryker | 2 | $141 |
| Immunogen, Inc. | 1 | $119 |
| Biontech SE | 1 | $118 |
| Seagen Inc. | 1 | $113 |
| Gilead | 3 | $92 |
| Karyopharm Therapeutics Inc. | 1 | $85 |
| Novocure Inc. | 1 | $58 |
| Genentech, Inc. | 1 | $42 |
| Tesaro, Inc. | 1 | $30 |
| Novartis | 1 | $25 |
| Mirati Therapeutics, Inc. | 1 | $20 |
| Foundation Medicine, Inc. | 1 | $19 |
| Tempus AI, Inc | 1 | $18 |
| Sanofi | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Clovis Oncology, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$5,585
- EPKINLY$1,965
- ZEJULA$1,300
- Elahere$480
- SPY-PHI SYSTEM$126
How this compares
$17,948 in reported general payments places this provider in the 75th percentile of 135 gynecologic oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LenvimaLenvatinib Mesylate | 12 | $278,091 |
| Megestrol Acetate | 21 | $1,672 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 82 | $1,098 |
| Dexamethasone | 26 | $452 |
| Letrozole | 22 | $378 |
| Gabapentin | 29 | $187 |
| Imiquimod | 11 | $118 |
| Ondansetron Hcl | 19 | $97 |
| Tramadol Hcl | 20 | $96 |
| Olanzapine | 17 | $49 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Fort Worth
- Reagan StreetFort Worth$280K
- Tiffany RedfernFort Worth$165K
- Christopher LafargueFort Worth$26K
- de Ette VasquesFort Worth$19K
- Graham BrownFort Worth$5K
- Robert ColemanHouston$864K
- Joseph de la GarzaSan Antonio$234K
- Maurie MarkmanHouston$204K
- Dustin MandersDallas$171K
- Antonio Santillan-GomezSan Antonio$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.